This provider's $5.4M in total Medicare payments ranks in the 82th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 328% from 2022 to 2023.
79% of their billing comes from a single procedure code (K1034 — Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count).
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 328% in 2023
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2022 | $208.84 | $107.12 | 1.95x | $101.72 | $1.0M | 9.6K | 21 |
| 2023 | $25.47 | $12.60 | 2.02x | $12.87 | $4.4M | 349.3K | 6 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 355.4K | $4.2M | $11.76 | 2.04x |
| 81443 | Genomic sequence analysis panel for severe inherited conditions with sequencing of 15 or more genes | 82 | $196.8K | $2.4K | 2.04x |
| 81419 | Gene analysis panel for evaluation of genes associated with epilepsy | 44 | $105.6K | $2.4K | 2.04x |
| 81307 | Gene analysis (partner and localizer of brca2) full sequence analysis | 128 | $84.9K | $663.39 | 2.04x |
| 81317 | Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis | 123 | $81.6K | $663.41 | 2.04x |
| 81298 | Gene analysis (muts homolog 6 [e coli]) full sequence analysis | 124 | $78.0K | $629.42 | 2.04x |
| 81223 | Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence | 154 | $75.3K | $489.25 | 2.04x |
| 81185 | Gene analysis (calcium voltage-gated channel subunit alpha1 a) of full sequence | 83 | $68.8K | $829.34 | 1.53x |
| 81249 | Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis | 116 | $68.2K | $588.00 | 2.04x |
| 81325 | Gene analysis (peripheral myelin protein 22), full sequence analysis | 87 | $65.6K | $754.19 | 1.53x |
| 81238 | Gene analysis (coagulation factor ix) full sequence analysis | 106 | $62.3K | $588.00 | 2.04x |
| 81302 | Gene analysis (methyl cpg binding protein 2) full sequence analysis | 91 | $47.1K | $517.31 | 2.04x |
| 81448 | Gene analysis panel for hereditary disorders of the peripheral nervous system | 82 | $47.0K | $573.20 | 2.04x |
| 81189 | Gene analysis (cystatin b) of full sequence | 89 | $24.0K | $269.33 | 1.53x |
| 81309 | Gene analysis (partner and localizer of brca2) targeted sequence analysis | 89 | $24.0K | $269.33 | 1.53x |
| 81339 | Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 | 123 | $22.3K | $181.50 | 2.04x |
| 81400 | Molecular pathology procedure level 1 | 333 | $20.9K | $62.71 | 1.02x |
| 81286 | Gene analysis (frataxin) of full sequence | 76 | $20.5K | $269.33 | 1.53x |
| 81191 | Gene analysis (neurotrophic receptor tyrosine kinase 1) translocation analysis | 89 | $18.1K | $203.16 | 1.53x |
| 81192 | Gene analysis (neurotrophic receptor tyrosine kinase 2) translocation analysis | 89 | $18.1K | $203.16 | 1.53x |
This provider submits charges 2.01 times higher than what Medicare actually pays.
A markup ratio of 2.01x means for every $100 Medicare pays, this provider initially charges $201. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in OK for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Diagnostic Laboratory Of Oklahoma Llc | Oklahoma City, OK | $129.7M | ⚠️ Flagged |
| Saint Francis Outreach Services Llc | Tulsa, OK | $50.6M | ⚠️ Flagged |
| Dianon Systems Inc | Oklahoma City, OK | $37.7M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data